Title |
Escitalopram versus other antidepressive agents for depression
|
---|---|
Published in |
Cochrane database of systematic reviews, April 2009
|
DOI | 10.1002/14651858.cd006532.pub2 |
Pubmed ID | |
Authors |
Andrea Cipriani, Claudio Santilli, Toshi A Furukawa, Alessandra Signoretti, Atsuo Nakagawa, Hugh McGuire, Rachel Churchill, Corrado Barbui |
Abstract |
Although pharmacological and psychological interventions are both effective for major depression, antidepressant drugs remain the mainstay of treatment in primary and secondary care settings. During the last 20 years, antidepressant prescribing has risen dramatically in western countries, mainly because of the increasing consumption of selective serotonin reuptake inhibitors (SSRIs) and newer antidepressants, which have progressively become the most commonly prescribed antidepressants. Escitalopram is the pure S-enantiomer of the racemic citalopram. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 50% |
Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 2 | <1% |
Brazil | 2 | <1% |
Hong Kong | 1 | <1% |
Austria | 1 | <1% |
Colombia | 1 | <1% |
India | 1 | <1% |
United Kingdom | 1 | <1% |
Australia | 1 | <1% |
Mexico | 1 | <1% |
Other | 3 | <1% |
Unknown | 399 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 70 | 17% |
Researcher | 50 | 12% |
Student > Bachelor | 49 | 12% |
Student > Ph. D. Student | 33 | 8% |
Other | 26 | 6% |
Other | 86 | 21% |
Unknown | 99 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 149 | 36% |
Psychology | 46 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 22 | 5% |
Nursing and Health Professions | 17 | 4% |
Agricultural and Biological Sciences | 15 | 4% |
Other | 53 | 13% |
Unknown | 111 | 27% |